BRIEF-Bayer's Xofigo attested to have considerable benefit by German reimbursement agency

June 19 Thu Jun 19, 2014 11:08am EDT

Related Topics

June 19 (Reuters) - Bayer AG : * Says Xofigo drug attested to have considerable benefit in treating certain

prostate cancer types by German reimbursement agency G-BA

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.